We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLYS icon
926
Qualys
QLYS
$4.76B
$519K ﹤0.01%
4,038
-608
-13% -$80.3K
RIO icon
927
Rio Tinto
RIO
$152B
$518K ﹤0.01%
7,282
-3,923
-35% -$252K
IEX icon
928
IDEX
IEX
$17B
$514K ﹤0.01%
2,396
-12
-0.5% -$2.42K
EXEL icon
929
Exelixis
EXEL
$13.9B
$513K ﹤0.01%
19,761
+118
+0.6% +$2.93K
ZBRA icon
930
Zebra Technologies
ZBRA
$13.5B
$512K ﹤0.01%
1,382
+332
+32% +$112K
TTWO icon
931
Take-Two Interactive
TTWO
$46.1B
$507K ﹤0.01%
3,296
+41
+1% +$6.22K
ICF icon
932
iShares Select U.S. REIT ETF
ICF
$2.13B
$505K ﹤0.01%
7,658
– –
KBR icon
933
KBR
KBR
$4.56B
$504K ﹤0.01%
+7,743
New +$504K
ADUS icon
934
Addus HomeCare
ADUS
$2.22B
$491K ﹤0.01%
+3,694
New +$466K
NGG icon
935
National Grid
NGG
$79.3B
$488K ﹤0.01%
7,427
+414
+6% +$25.4K
LAZ icon
936
Lazard
LAZ
$4B
$487K ﹤0.01%
+9,675
New +$448K
STX icon
937
Seagate
STX
$173B
$487K ﹤0.01%
4,450
+384
+9% +$39.3K
CCEP icon
938
Coca-Cola Europacific Partners
CCEP
$49.1B
$486K ﹤0.01%
6,169
+77
+1% +$5.9K
NCNO icon
939
nCino
NCNO
$2.06B
$485K ﹤0.01%
+15,362
New +$486K
PODD icon
940
Insulet
PODD
$11.8B
$484K ﹤0.01%
2,080
+47
+2% +$9.65K
GDDY icon
941
GoDaddy
GDDY
$13.9B
$484K ﹤0.01%
3,086
+902
+41% +$138K
CALM icon
942
Cal-Maine
CALM
$4.43B
$483K ﹤0.01%
6,450
+1
+0% +$69
EWTX icon
943
Edgewise Therapeutics
EWTX
$4.28B
$483K ﹤0.01%
+18,085
New +$360K
ING icon
944
ING
ING
$92.9B
$481K ﹤0.01%
26,462
+1,287
+5% +$23K
VCEL icon
945
Vericel Corp
VCEL
$2.38B
$480K ﹤0.01%
11,363
+108
+1% +$5.14K
HEI icon
946
HEICO Corp
HEI
$49.6B
$479K ﹤0.01%
1,833
+7
+0.4% +$1.69K
KBH icon
947
KB Home
KBH
$3.5B
$478K ﹤0.01%
5,579
+119
+2% +$9.57K
SIGI icon
948
Selective Insurance
SIGI
$5.76B
$476K ﹤0.01%
5,101
+155
+3% +$14K
AMWD
949
DELISTED
American Woodmark
AMWD
$475K ﹤0.01%
5,080
+222
+5% +$20K
GNTX icon
950
Gentex
GNTX
$5.1B
$474K ﹤0.01%
15,979
-30,348
-66% -$943K
36 37
38
39 40

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.